Brief: India's Ajanta Pharma Sept-Quarter Consol Net Profit Rises
Oct 31 (Reuters) - Ajanta Pharma Ltd AJPH.NS :
* SEPT-QUARTER CONSOL NET PROFIT 1.95 BILLION RUPEES VERSUS
1.57
BILLION RUPEES
* SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 10.28 BILLION
RUPEES
VERSUS 9.38 BILLION RUPEES
Further company coverage: AJPH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility